当前位置： SCI文献检索 > JAPANESE JOURNAL OF CLINICAL ONCOLOGY期刊下所有文献 > Hyperfractionated radiation therapy for locoregionally advanced nasopharyngeal cancer.

Hyperfractionated radiation therapy for locoregionally advanced nasopharyngeal cancer.

Abstract：

OBJECTIVE:The purpose of this study is to clarify the efficacy and toxicity of hyperfractionated radiation therapy (RT) for patients with nasopharyngeal cancer (NPC). METHODS:Twenty-two patients with NPC treated at our hospital between April 1994 and December 2002 were the subjects of this study. They received hyperfractionated RT with a fraction size of 1.2 Gy, with a median tumor dose of 72 Gy (range 64.8-80.4). During this study period, our institutional strategy for locoregionally advanced NPC included neoadjuvant or concurrent chemotherapy combined with hyperfractionated RT, and 17 patients received some forms of cisplatin-containing chemotherapy. RESULTS:With a median follow-up of 59 months, the estimated 5-year disease-free survival rate and overall survival rate were 72.7 and 85.2%, respectively. Acute hematological toxicities were acceptable and manageable. However, >50% of patients required nutritional support, and experienced severe pharyngitis, skin reaction and body weight loss. With regard to late sequelae, one patient developed grade 3 osteomyelitis, and one patient each developed grade 4 passage disturbance and laryngeal edema. No patients experienced any grades of optic nerve injury or temporal lobe necrosis. CONCLUSIONS:Hyperfractionated RT using 1.2 Gy per fraction, for a total dose of 72 Gy, produces a comparable treatment outcome. Although deleterious neurological sequelae were not observed in this study, caution should be exercised regarding other late sequelae, such as osteomyelitis and passage disturbance.

journal_name

Jpn J Clin Oncol

journal_title

Japanese journal of clinical oncology

authors

Isobe K,Uno T,Kawakami H,Ueno N,Aruga T,Yasuda S,Hanazawa T,Okamoto Y,Ito H,Shigematsu N

doi

10.1093/jjco/hyi041

keywords:

subject

Has Abstract

pub_date

2005-03-01 00:00:00

pages

116-20

issue

3

eissn

0368-2811

issn

1465-3621

pii

35/3/116

journal_volume

35

pub_type

杂志文章

相关文献

JAPANESE JOURNAL OF CLINICAL ONCOLOGY文献大全
  • A phase 2 trial of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer and without prior chemotherapy (JPN-201 study).

    abstract：OBJECTIVE:Abiraterone acetate has been approved in >70 countries for chemotherapy-naïve metastatic castration-resistant prostate cancer patients. Efficacy and safety of abiraterone acetate (1000 mg/once daily) with prednisolone (5 mg/twice daily) in chemotherapy-naïve Japanese patients with metastatic castration-resist...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyu149

    authors： Matsubara N,Uemura H,Satoh T,Suzuki H,Nishiyama T,Uemura H,Hashine K,Imanaka K,Ozono S,Akaza H

    更新日期：2014-12-01 00:00:00

  • Should ipsilateral solitary adrenal involvement in renal cell carcinoma be staged as M1?

    abstract：OBJECTIVE:In 2009, the TNM classification of malignant tumors was revised, and the renewal of the T2-4 stage in renal cell carcinoma was adopted. To date, however, the staging of ipsilateral solitary adrenal involvement in renal cell carcinoma has not been sufficiently evaluated. METHODS:We retrospectively reviewed th...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1093/jjco/hyr031

    authors： Takayama T,Sugiyama T,Kai F,Ito T,Furuse H,Mugiya S,Ozono S

    更新日期：2011-06-01 00:00:00

  • Treatment outcomes of the patients with early glottic cancer treated with initial radiotherapy and salvaged by conservative surgery.

    abstract：OBJECTIVE:This retrospective study analyzed the oncological and treatment outcomes of the patients with T1-T2N0 glottic cancer, who were treated with radiotherapy as initial treatment and salvaged by conservative surgery for radiation failure. METHODS:Between May 1999 and December 2010, 115 patients with glottic laryn...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyu203

    authors： Harada A,Sasaki R,Miyawaki D,Yoshida K,Nishimura H,Ejima Y,Kitajima K,Saito M,Otsuki N,Nibu K

    更新日期：2015-03-01 00:00:00

  • Interactions of lung cancer cells with the human mesothelial cell monolayer: an in vitro model for cancer invasion.

    abstract：:An in vitro monolayer model for cancer invasion was developed, comprising cultured layers of human pleura-derived mesothelial cells (PM cells). The cells were isolated from normal human pleura at autopsy and cultured in RPMI-1640 supplemented with 10% fetal calf serum; they were polygonal in shape, forming a pavement-...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：

    authors： Horai T,Imamura F,Nakae T,Nakamura S,Mukai M,Shinkai K,Higashino K,Akedo H

    更新日期：1992-04-01 00:00:00

  • The prognostic signature of the somatic mutations in Ewing sarcoma: from a network view.

    abstract：BACKGROUND:Ewing sarcoma is a malignant bone tumor mainly affecting teenagers and young adults. Its main driver mutation, the EWS-FLI1 fusion gene, has been identified more than 20 years ago, whereas its other somatic mutations have been just recently reported. METHODS:In this study, we organized the somatic mutations...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyz037

    authors： Zhang Y,Song J,Shi Q,Song X,Shen L,Zhou J,Shao J

    更新日期：2019-07-01 00:00:00

  • Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.

    abstract：OBJECTIVE:Alpha-fetoprotein (AFP) is an important tumor marker for non-seminomatous germ cell tumors (NSGCTs) that greatly affects diagnosis and the evaluations of therapy and therapeutic policy. However, it is sometimes very difficult to make the distinction between tumors and falsely elevated AFP levels due to benign...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyf094

    authors： Kamoto T,Satomura S,Yoshiki T,Okada Y,Henmi F,Nishiyama H,Kobayashi T,Terai A,Habuchi T,Ogawa O

    更新日期：2002-11-01 00:00:00

  • Genetic alterations of androgen receptor gene in Japanese human prostate cancer.

    abstract：:In order to determine the significance of androgen receptor (AR) gene mutations for Japanese prostate cancers, we examined the entire coding region, from exon A to H, in 36 primary lesions. Five in stage A, 12 in stage B, six in stage C and 13 in stage D were subjected to PCR-SSCP analysis for genomic DNA and nucleoti...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/27.6.389

    authors： Watanabe M,Ushijima T,Shiraishi T,Yatani R,Shimazaki J,Kotake T,Sugimura T,Nagao M

    更新日期：1997-12-01 00:00:00

  • Myoepithelioma occurring in the posterior mediastinum harboring EWSR1 rearrangement: a case report.

    abstract：:Myoepithelioma is a rare neoplasm usually occurring in the salivary glands or the mammary glands but also, more rarely, in the thoracic cavity. The diagnosis of myoepithelioma is based on the presence of histological and immunohistochemical characteristics of myoepithelioma, but in unusual locations, the diagnosis is ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyy100

    authors： Habu T,Soh J,Toji T,Shien K,Niman E,Namba K,Sato H,Yamamoto H,Sugimoto S,Yamane M,Toyooka S

    更新日期：2018-09-01 00:00:00

  • Publication of lung cancer clinical trials in the Japanese Clinical Trial Registry.

    abstract：Introduction:Since June 2005, the University Hospital Medical Information Network-Clinical Trial Registry (UMIN-CTR) has been an International Committee of Medical Journal Editors (ICMJE)-approved clinical trial registry in Japan. The number of clinical trials registered in the UMIN-CTR has increased annually. To date,...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyy131

    authors： Ochi N,Kawahara T,Nagasaki Y,Nakagawa N,Yamagishi T,Umemura S,Honda Y,Nakanishi H,Yamane H,Takigawa N

    更新日期：2018-11-01 00:00:00

  • Feasibility study of combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection for intermediate-to-high risk or recurrent endometrial cancer.

    abstract：OBJECTIVE:We evaluated the feasibility of combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection for intermediate-to-high-risk or recurrent endometrial cancer. METHODS:Women with histologically confirmed FIGO Stages I-II with >1/2 myomet...

    journal_title：Japanese journal of clinical oncology

    pub_type： 临床试验,杂志文章

    doi：10.1093/jjco/hyu124

    authors： Nagao S,Nishikawa T,Hanaoka T,Kurosaki A,Iwasa N,Hasegawa K,Fujiwara K

    更新日期：2014-11-01 00:00:00

  • Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policy.

    abstract：:Due to the rapid aging of Japan's population, clinical research focusing on older patients with cancer is urgently needed. The Japan Clinical Oncology Group (JCOG) has conducted several such clinical trials, but there has been no formal policy for geriatric research. We have therefore established a JCOG policy for ger...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyz093

    authors： Mizutani T,Nakamura K,Fukuda H,Ogawa A,Hamaguchi T,Nagashima F,Geriatric Study Committee\/Japan Clinical Oncology Group.

    更新日期：2019-10-01 00:00:00

  • Mass screening for gastric cancer by X-ray examination.

    abstract：:The characteristics of early gastric cancer detected by gastric mass survey were examined. The progress of the screening test using the indirect X-ray examination and the tendency toward reduction in mortality from stomach cancer were evaluated. In 1981 the number of examinees in the gastric mass surveys amounted to o...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：

    authors： Hisamichi S,Sugawara N

    更新日期：1984-06-01 00:00:00

  • Correlated expression of mRNAs of carcinoembryonic antigen and nonspecific cross-reacting antigen genes in malignant and nonmalignant tissues of the colon.

    abstract：:Expression of carcinoembryonic antigen (CEA) and nonspecific cross-reacting antigen (NCA) mRNAs were observed in malignant and nonmalignant colon tissues by Northern blot analysis. CEA mRNA was detected together with NCA mRNA in nine cultured cell lines, with the exception of the lung carcinoma A549 cell line, and in ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/oxfordjournals.jjco.a039449

    authors： Hinoda Y,Takahashi H,Higashide T,Nakano T,Arimura Y,Yoshimoto M,Tsujisaki M,Imai K,Yachi A

    更新日期：1991-04-01 00:00:00

  • A case of acute exacerbation of idiopathic pulmonary fibrosis after proton beam therapy for non-small cell lung cancer.

    abstract：:There have been no reports describing acute exacerbations of idiopathic pulmonary fibrosis after particle radiotherapy for non-small cell lung cancer. The present study describes the case of a 76-year-old Japanese man with squamous cell carcinoma of the lung that relapsed in the left upper lobe 1 year after right uppe...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hys115

    authors： Nagano T,Kotani Y,Fujii O,Demizu Y,Niwa Y,Ohno Y,Nishio W,Itoh T,Murakami M,Nishimura Y

    更新日期：2012-10-01 00:00:00

  • An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer.

    abstract：BACKGROUND:Oral carmofur, either as a single or in combination with other chemotherapeutic agents, has been used as adjuvant chemotherapy for curatively resected colon cancer patients. Past trials and meta-analyses indicate that it is somewhat effective in extending survival of patients with this cancer. The objective ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,meta分析

    doi：10.1093/jjco/hyi147

    authors： Sakamoto J,Hamada C,Rahman M,Kodaira S,Ito K,Nakazato H,Ohashi Y,Yasutomi M

    更新日期：2005-09-01 00:00:00

  • Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma.

    abstract：:Twenty-six patients with advanced bronchogenic adenocarcinoma or large cell carcinoma were treated by combination chemotherapy consisting of Ftorafur, adriamycin and mitomycin C (FAM II). The patients had not received prior chemotherapy and were not eligible for radiotherapy and surgery. The overall response rate was ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：

    authors： Salvati F,Cruciani AR,De Marinis A,Nunziati F,Portalone L

    更新日期：1984-03-01 00:00:00

  • Quantification of the increase in thyroid cancer prevalence in Fukushima after the nuclear disaster in 2011--a potential overdiagnosis?

    abstract：:A thyroid ultrasound examination programme has been conducted in Fukushima Prefecture, Japan, after the nuclear disaster in 2011. Although remarkably high prevalence of thyroid cancer was observed, no relevant quantitative evaluation was conducted. We calculated the observed/expected (O/E) ratio of thyroid cancer prev...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyv191

    authors： Katanoda K,Kamo K,Tsugane S

    更新日期：2016-03-01 00:00:00

  • Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients.

    abstract：OBJECTIVE:Osteosarcoma is the most common primary malignant bone tumor. The long-term outcome is poor for patients with metastatic disease. METHODS:From June 1989 to January 2008, 202 patients (128 males and 74 females) with high-grade osteosarcoma of the extremities were treated at our institution. Patients were divi...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyp057

    authors： Wu PK,Chen WM,Chen CF,Lee OK,Haung CK,Chen TH

    更新日期：2009-08-01 00:00:00

  • Correlation of biologically effective dose and the tumor control in Stage I (

    abstract：Backgrounds:Stereotactic ablative radiotherapy (SABR) is one of the newly developed innovative radiotherapy and of which optimal dose prescription needs to be standardized. We aimed to investigate the dose-response relationship for patients with SABR. Methods:Fifty-three patients with Stage I non-small cell lung cance...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyx172

    authors： Jeon W,Ahn SJ,Kim YC,Oh IJ,Park CK,Jeong JU,Yoon MS,Song JY,Nam TK,Chung WK

    更新日期：2018-02-01 00:00:00

  • A phase III randomized controlled trial comparing surgery plus adjuvant chemotherapy with preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for locally recurrent rectal cancer: Japan Clinical Oncology Group study JCOG1801 (RC-S

    abstract：:A randomized phase III trial was initiated in Japan in August 2019 to confirm the superiority of preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy compared to the standard treatment, i.e. surgery plus adjuvant chemotherapy, for locally recurrent rectal cancer in local relapse-free survival....

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,随机对照试验

    doi：10.1093/jjco/hyaa058

    authors： Kadota T,Tsukada Y,Ito M,Katayama H,Mizusawa J,Nakamura N,Ito Y,Bando H,Ando M,Onaya H,Fukuda H,Kanemitsu Y

    更新日期：2020-08-04 00:00:00

  • Study of paclitaxel and dose escalation of cisplatin in patients with advanced non-small cell lung cancer.

    abstract：BACKGROUND:We conducted a dose-finding and feasibility study in which we administered a fixed dose 3-h infusion of paclitaxel and an escalating dose of cisplatin in Japanese patients with advanced non-small cell lung cancer. METHODS:Chemotherapy consisted of fixed dose (210 mg/m(2)) paclitaxel given over 3 h on day 1 ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyg116

    authors： Watanabe H,Yamamoto N,Tamura T,Shimoyama T,Hotta K,Inoue A,Sawada M,Akiyama Y,Kusaba H,Nokihara H,Sekine I,Kunitoh H,Ohe Y,Kodama T,Saijo N

    更新日期：2003-12-01 00:00:00

  • The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas.

    abstract：OBJECTIVE:We reviewed the relationship between extent of resection and survival of patients with high-grade gliomas with special consideration of an oligodendroglial component. METHODS:A retrospective review was performed on 160 adult patients with histological diagnosis of high-grade gliomas since 2000. All histologi...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hys016

    authors： Yamaguchi S,Kobayashi H,Terasaka S,Ishii N,Ikeda J,Kanno H,Nishihara H,Tanaka S,Houkin K

    更新日期：2012-04-01 00:00:00

  • Hematogenous metastatic patterns of curatively resected colon cancer were different from those of stage IV and autopsy cases.

    abstract：:The hematogenous metastases of colon cancer have primarily been explained by the cascade hypothesis based on the cadaveric study. However, we experienced several cases with isolated lung metastasis. The metastatic patterns of a total of 982 patients with colon cancer who underwent surgery were reviewed. The incidence ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyt002

    authors： Sadahiro S,Suzuki T,Tanaka A,Okada K,Kamata H

    更新日期：2013-04-01 00:00:00

  • Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).

    abstract：BACKGROUND:In Japan, concurrent chemoradiotherapy is the standard treatment for unresectable esophageal cancer. The optimal combination of chemotherapeutic agents and radiotherapy dose remains controversial. The present study consists of a phase II trial of a cisplatin (CDDP)/5-fluorouracil (5-FU) infusion with concurr...

    journal_title：Japanese journal of clinical oncology

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1093/jjco/hyh107

    authors： Ishida K,Ando N,Yamamoto S,Ide H,Shinoda M

    更新日期：2004-10-01 00:00:00

  • Surgical management of renal cell carcinoma extended into the vena cava and the right atrium.

    abstract：:The present report describes two cases of renal cell carcinoma extending into the vena cava and the right atrium. The treatment was total nephrectomy and tumor thrombectomy, utilizing extracorporeal circulation. The aggressive surgical management of this progressive malignant disease is discussed. ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：

    authors： Cho M,Ozono S,Takashima K,Moriya A,Hirao Y,Okajima E,Taniguchi S,Niwaya K,Kawachi K,Kitamura S

    更新日期：1989-12-01 00:00:00

  • Analysis of myelodysplastic syndrome clones arising after multiple myeloma: a case study by correlative interphase cytogenetic analysis.

    abstract：BACKGROUND:A patient with multiple myeloma developed myelodysplastic syndrome (MDS). Chromosomal analysis performed after the development of MDS revealed monosomy of chromosome 9 in all the meta-phases. We wished to identify the extent of the clone with the chromosomal abnormality originating from MDS clone. METHODS:A...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/29.8.374

    authors： Kobayashi Y,Nakayama M,Uemura N,Takeyama K,Tobinai K,Takenaka T,Choi SH,Satoh H,Mori S,Asano S

    更新日期：1999-08-01 00:00:00

  • A new method of preparing specimens for cytodiagnosis of lung cancer.

    abstract：:A simple and effective method for concentrating sputum in the preparation of smears for cytodiagnosis of lung cancer was developed. The procedure, which utilizes a fixative consisting of 2,3-dihydroxy-1,4-dithiol-butane, 3,5-ditert-butyl-4-hydroxy-toluene, polyoxyethylene-cetyl-ether, polyethylene glycol 1540, and eth...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：

    authors： Yamagishi K,Koketsu H,Tajima M,Suemasu K

    更新日期：1985-06-01 00:00:00

  • Health behaviors of cancer survivors: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV, 2007-09).

    abstract：OBJECTIVE:This study aimed to describe the health behaviors of cancer survivors in the Republic of Korea and to compare them with the health behaviors of two control groups: (i) individuals with no history of cancer but with other chronic diseases and (ii) individuals with no history of cancer or other chronic diseases...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyt118

    authors： Oh MG,Han MA,Park J,Ryu SY,Park CY,Choi SW

    更新日期：2013-10-01 00:00:00

  • Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma.

    abstract：OBJECTIVE:To retrospectively examine the outcomes of hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannomas. METHODS:Twenty-five patients with 26 vestibular schwannomas were treated with hypofractionated stereotactic radiation therapy using a CyberKnife. The vestibular sc...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyt082

    authors： Morimoto M,Yoshioka Y,Kotsuma T,Adachi K,Shiomi H,Suzuki O,Seo Y,Koizumi M,Kagawa N,Kinoshita M,Hashimoto N,Ogawa K

    更新日期：2013-08-01 00:00:00

  • Proposal for the breakdown of increased cancer healthcare cost and its improvement.

    abstract：:Technological progress in the field of cancer treatment can be expected to accelerate in the future, giving hope to such patients. At the same time, there is concern that cancer care will become more expensive. It is indispensable to minimize the economic burden of patients to deliver technological advances in treatme...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1093/jjco/hyt015

    authors： Koinuma N

    更新日期：2013-04-01 00:00:00